Dimensional U.S. Small Cap ETF (DFAS)
| Assets | $15.11B |
| Expense Ratio | 0.26% |
| PE Ratio | 16.17 |
| Shares Out | 191.82M |
| Dividend (ttm) | $0.81 |
| Dividend Yield | 1.03% |
| Ex-Dividend Date | Sep 22, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 16.73% |
| Volume | 436,883 |
| Open | 77.53 |
| Previous Close | 77.92 |
| Day's Range | 77.31 - 78.16 |
| 52-Week Low | 77.05 |
| 52-Week High | 79.52 |
| Beta | n/a |
| Holdings | 2058 |
| Inception Date | Dec 15, 1998 |
About DFAS
Fund Home PageThe Dimensional U.S. Small Cap ETF (DFAS) is an exchange-traded fund that mostly invests in small-cap stocks. The fund actively invests in small-cap US companies, selected using multiple factors and weighted by market capitalization. DFAS was launched on Dec 15, 1998 and is issued by Dimensional.
Top 10 Holdings
2.69% of assets| Name | Symbol | Weight |
|---|---|---|
| Charles River Laboratories International, Inc. | CRL | 0.28% |
| WESCO International, Inc. | WCC | 0.28% |
| APA Corporation | APA | 0.28% |
| TTM Technologies, Inc. | TTMI | 0.27% |
| DigitalOcean Holdings, Inc. | DOCN | 0.27% |
| Onto Innovation Inc. | ONTO | 0.26% |
| Applied Industrial Technologies, Inc. | AIT | 0.26% |
| Jazz Pharmaceuticals plc | JAZZ | 0.26% |
| IES Holdings, Inc. | IESC | 0.26% |
| Halozyme Therapeutics, Inc. | HALO | 0.26% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 22, 2026 | $0.20035 | Sep 24, 2026 |
| Jun 23, 2026 | $0.23959 | Jun 25, 2026 |
| Mar 24, 2026 | $0.16541 | Mar 26, 2026 |
| Dec 16, 2025 | $0.20061 | Dec 18, 2025 |
| Sep 23, 2025 | $0.18833 | Sep 25, 2025 |
| Jun 24, 2025 | $0.17005 | Jun 26, 2025 |
News
Dimensional's ‘New' ETFs Are Really ETF Share Classes
Three Dimensional Fund Advisors ETFs that NYSE Arca announced as Monday launches are not new funds at all. Instead, they are existing ETFs that now trade as share classes of older Dimensional mutual f...
4 ETFs to Consider From an Undervalued Part of the Market
And what to look for when shopping for one.
3 Great Small-Cap ETFs for 2025
Zachary Evens: Small stocks have underperformed their larger counterparts for a long time, prompting some people, including myself, to ask: why bother with small-cap ETFs? While there's an argument to...
ETF Edge: Getting active with small caps
Rob Harvey, Vice President of Dimensional Funds, and Ben Slavin, Global Head of ETFs for BNY Mellon, join CNBC's Bob Pisani on the ‘Halftime Report' to discuss the alternatives to small cap ETFs.
Citi Supports the Industry's Largest Mutual Fund to ETF Conversion
NEW YORK--(BUSINESS WIRE)--Citi has successfully supported the industry's largest mutual fund to ETF conversion for Dimensional Fund Advisors. The conversion includes four US tax-managed mutual funds ...
Dimensional just converted $30 billion worth of mutual funds to ETFs. What it could mean for the industry
The exchange-traded fund format should bolster Dimensional's tax-efficient strategy for some of its mutual funds, the firm's co-CEO says.
Dimensional completes largest mutual fund-to-ETF conversion to date
Gerard O'Reilly, co-CEO and chief investment officer of Dimensional Funds, and Dave Nadig, chief investment officer and director of research at ETF Trends, discuss Dimensional's $30 billion mutual fun...
Why Dimensional Converted $29B of Mutual Funds Into ETFs
Jun.14 -- Dimensional Fund Advisors Co-CEO Gerard O'Reilly discusses the factors behind his firm's decision to convert four equity mutual funds with $28.8 billion of assets into ETFs. He speaks on "Bl...